Streptococcus group B [GBS] - characteristic, occurrence in children and adolescents with type 1 diabetes mellitus

• Autorzy: Nowakowska M , Jarosz-Chobot P.
• Języki publikacji: EN

Abstrakty

EN

Group B streptococcus causes infections in woman during pregnancy and confinement, perinatal infections in newborns related to mothers carrier-state and in adults, mostly in the elderly, with one or more predisposing to infections conditions. Diabetes mellitus is the most common underlying condition. The aim of the study was to determine the frequency of GBS occurrence and GBS antibiotic susceptibility in children and adolescents with type 1 diabetes mellitus. In years 2000-2002 occurrence of GBS in some clinical materials (urine, swabs from pharynx and urogenital tract) taken from 161 diabetics: 90 girls and 71 boys, hospitalized for newly diagnosed diabetes or insufficient metabolic control/longer duration of diabetes and 37 children with hypostatura (control group) aged from 5-17 years, was examined. Susceptibility of isolated GBS strains to ampicillin, erythromycin and clindamycin was determined. GBS were obtained from different materials from 36 (22.4%) diabetic children - 25 girls (27.8%), and 11 boys (15.5%). In all examined groups GBS was detected significantly in children with insufficient metabolic control/longer duration of diabetes (27 of 36 children; p=0.029, x²=4.773). GBS in girls was isolated mainly from vestibule of vagina (25 cases) and in few cases (4) from the pharynx. GBS in boys was grown from materials from urethra (6 cases) and pharynx (5 cases). In the control group, GBS colonization was observed only in one case. All isolates (40 strains) were susceptible to penicillins, however lower susceptibility to erythromycin (3 resistant and 1 moderately sensitive) and clindamycin (3 resistant) were observed. High percentage of carriers of GBS both in girls and boys with diabetes mellitus is the potential risk factor of infection caused by GBS.

Słowa kluczowe

EN

pregnancy; diabetes type 1; human infection; perinatal infection; diabetes mellitus; Streptococcus agalactiae; child; woman; occurrence; newborn; group B streptococcus

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2004
• Tom: 53
• Numer: 1
• Opis fizyczny: p.17-22,fig.,ref.

Twórcy

autor

Nowakowska M

• Silesian Medical University, Medykow 18, 40-752 Katowice, Poland

autor

Jarosz-Chobot P.

Bibliografia

• Baltimore R.S., S.M. Huie, J.I. Meek, A. Schuchat and K.L. O'Brien. 2001. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 108: 1094-1098.
• Bevilacqua G. 1999. Prevention of perinatal infection caused by group B betahemolytic Streptococcus. Acta Biomed. Ateneo. Parmense. 70: 87-94.
• Dzierżanowska D. 2000. Order 3.3 Patogenicity and antibiotics susceptibility of the some main pathogen, Streptococcus agalactiae, p. 168-170. In: D. Dzierżanowska (ed.), Practical antibiotic terapy. a-Medica Press, Bielsko-Biała.
• Edwards M.S. and C.J. Baker. 2000. Chapter 190. Streptococcus agalactiae (group B streptococcus), p. 2156. In. G.L. Mandell, J.E. Bennett, R. Dolin, (eds), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone.
• Gardam M.A., D.E. Low, R. Singur and M.A. Miller. 1998. Group B streptococcal necrotising fasciitis and streptococcal shock-like syndrome in adults. Arch. Intern. Med. 158: 1704-1708.
• Honig E., W.J. Mouton and W.I. van der Meijden. 2002. The epidemiology of vaginal colonisation with group B streptococci in a sexually transmitted disease clinic. Eur. J. Obstet. Gynecol. Reprod. Biol. 105: 177-180. Hryniewicz W. and E. Gonera. 1993. Streptococcal infections, infections caused by Streptococcus agalactiae, p. 463. In: W. Magdzik (ed.), Infections and parasitic diseases. Prevention and control. 3rd ed. Vesalius, Kraków, (in Polish).
• Hryniewicz W. 2002. Clinical microbiology, (in Polish). Medycyna Praktyczna - Pediatria. 2: 26-31.
• Jackson L.A., R. Hilsdon, M.M. Farley, L.H. Harrison, A.L. Reingold, B.D. Plikaytis, J.D. Wegner and A. Schuchat. 1998. Risk factors for group B streptococcal disease in adults. Clin. Microbiol. Rev. 11: 497-513.
• Jeljaszewicz J. and J. Meszaros. 2001. Streptococcal infections, p. 497. In: W. Magdzik and D. Naruszewicz-Lesiuk (eds), Human infections and contagions. Epidemiology, prevention and control, (in Polish) l sh ed. PZWL Warszawa.
• Lin F-Y.C, P.H. Azimi, L.E. Weisman, J.B. Philips III, J. Regan, P. Clark, G.G. Rhosds, J. Clemens, J. Troendie, E. Pratt, R.A. Brenner and V. Gill. 2000. Antibiotic susceptibility profdes for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. Dis. 31: 76-79.
• Liotta A., F. Cardella, D. Ferrara, D. Natoli, G. Licastro, F. Meli and S. Teresi. 1987. Vaginal infections in a population of diabetic children and adolescents. Pediatr. Med. Chir. 9: 305-308.
• Lyytikainen O., J.P. Nuorti, E. Halmesmaki, P. Carlson, J. Uotila, R. Vuento, T. Ranta, H. Sarkkinen, M. Ammala, A. Kostiala and A.L. Jarvenaa. 2003. Invasive group B streptococcal infections in Finland: a population - based study. Emerg. Infect. Dis. 9: 469-473.
• Munoz P., A. Llancaqueo, M. Rodriguez-Creixems, T. Pelaez, L. Martin and E. Bouza. 1997. Group B streptococcus bacteremia in nonpregnant adults. Arch. Intern. Med. 157: 213-216.
• Murdoch D.R. and L.B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother 45: 3623-3624.
• National Committee for Clinical Laboratory Standards (NCCLS): Performance standards for antimicrobial disc susceptibility tests 1997. 6th ed. Approved standard M2-A6. NCCLS, Villanova PA. 1997, vol. 17.
• Nolla J.M., C. Gomez-Vaquero, X. Corbella, S. Ordones, C. Garcia-Gomez, A. Perez, J. Cabo, J. Valverde and J. Ariza. 2003. Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine (Baltimore) 82: 119-128.
• Opal S.M., A. Cross, M. Palmer and R. Almazan. 1988. Group B streptococcal sepsis in adults and infants. Contrasts and comparisons. Arch. Intern. Med. 148: 641-645.
• Parker M.T. 1984. Streptococcal diseases, p. 225-253. In: Smith G.R. (ed.), Topley and Wilson's Principles of Bacteriology, Virology and Immunity, 7th edition, vol. 3, Bacterial diseases. Butler & Tanner, London.
• Pearlman M.D., C.L. Pierson and R.G. Faix. 1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92: 258-61.
• Poulain P., P. Betremieux, P.Y. Donnio, J.F. Proudhon, G. Karege and J.R. Giraud. 1997. Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur. J. Obstet. Gynecol. Reprod. Biol. 72: 137-140.
• Ruoff K.L., R.A. Whiley and D. Beighton. 1999. Streptococcus, p. 283 - 305. Murray P.R., E.J. Baron, M.A. Pfaller, F.C. Tenover and R.H. Yolken (eds), Mannual of Clinical Microbiology, 7th edition. American Society for Microbiology, Washington.
• Schrag S.J., S. Zywicki, M.M. Farley, A.L. Reingold, L.H. Harrison, L.B. Lefkowitz, J.L. Hadler, R. Danila, P.R. Cies1ak and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342: 15-20.
• Trivalle C, E. Martin, P. Martel, B. Jacque, J.F. Menard and J.F. Lemeland. 1998. Group B streptococcal bacteraemia in the elderly. J. Med. Microbiol. 47: 649-652.
• Tyrrell G.J., L.D. Senzilet, J.S. Spika and D.A. Kertesz. 2000. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study - 1996. J. Infect. Dis. 182: 168-173.